Prostate specific antigen values after radical retropubic prostatectomy for adenocarcinoma of the prostate

Impact of adjuvant treatment (Hormonal and radiation)

W. R. Morgan, H. Zincke, L. M. Rainwater, R. P. Myers, G. G. Klee

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

Prostate specific antigen (PSA) levels were obtained before and after radical retropubic prostatectomy in 192 patients: 78 (41%) had pathological stage B2 cancer or less, 83 (43%) had stage C or C+ and 31 (16%) had stage D1 disease. Of those with stages B2 or less, C, C+ and D1 disease 82, 86, 65 and 90%, respectively, had postoperative PSA values of 0.2 ng./ml. or less (when first evaluated 30 or more days postoperatively). At 1 year postoperatively 94% of the stages C and C+ cancer patients treated with adjuvant radiation had PSA levels of 0.2 ng./ml. or less, which was significantly different from those not treated adjuvantly (p = 0.02). This effect of adjuvant radiation on PSA was temporary in the small number of patients with longer followup. Adjuvant orchiectomy for stage D1 lesions resulted in female PSA levels in virtually all cases. This decrease may be misleading and may reflect a direct hormonal effect rather than a decrease in tumor volume. Positive surgical margins did not significantly affect postoperative PSA levels, possibly because of the frequent use of adjuvant treatment.

Original languageEnglish (US)
Pages (from-to)319-323
Number of pages5
JournalJournal of Urology
Volume145
Issue number2
StatePublished - 1991

Fingerprint

Prostate-Specific Antigen
Prostatectomy
Prostate
Adenocarcinoma
Radiation
Therapeutics
Orchiectomy
Radiation Effects
Tumor Burden
Neoplasms

Keywords

  • Adenocarcinoma
  • Antigens, differentiation
  • Hormone
  • Prostate
  • Radiotherapy

ASJC Scopus subject areas

  • Urology

Cite this

Prostate specific antigen values after radical retropubic prostatectomy for adenocarcinoma of the prostate : Impact of adjuvant treatment (Hormonal and radiation). / Morgan, W. R.; Zincke, H.; Rainwater, L. M.; Myers, R. P.; Klee, G. G.

In: Journal of Urology, Vol. 145, No. 2, 1991, p. 319-323.

Research output: Contribution to journalArticle

Morgan, W. R. ; Zincke, H. ; Rainwater, L. M. ; Myers, R. P. ; Klee, G. G. / Prostate specific antigen values after radical retropubic prostatectomy for adenocarcinoma of the prostate : Impact of adjuvant treatment (Hormonal and radiation). In: Journal of Urology. 1991 ; Vol. 145, No. 2. pp. 319-323.
@article{9f0c0ca702c04ed18945211d8b3a2e44,
title = "Prostate specific antigen values after radical retropubic prostatectomy for adenocarcinoma of the prostate: Impact of adjuvant treatment (Hormonal and radiation)",
abstract = "Prostate specific antigen (PSA) levels were obtained before and after radical retropubic prostatectomy in 192 patients: 78 (41{\%}) had pathological stage B2 cancer or less, 83 (43{\%}) had stage C or C+ and 31 (16{\%}) had stage D1 disease. Of those with stages B2 or less, C, C+ and D1 disease 82, 86, 65 and 90{\%}, respectively, had postoperative PSA values of 0.2 ng./ml. or less (when first evaluated 30 or more days postoperatively). At 1 year postoperatively 94{\%} of the stages C and C+ cancer patients treated with adjuvant radiation had PSA levels of 0.2 ng./ml. or less, which was significantly different from those not treated adjuvantly (p = 0.02). This effect of adjuvant radiation on PSA was temporary in the small number of patients with longer followup. Adjuvant orchiectomy for stage D1 lesions resulted in female PSA levels in virtually all cases. This decrease may be misleading and may reflect a direct hormonal effect rather than a decrease in tumor volume. Positive surgical margins did not significantly affect postoperative PSA levels, possibly because of the frequent use of adjuvant treatment.",
keywords = "Adenocarcinoma, Antigens, differentiation, Hormone, Prostate, Radiotherapy",
author = "Morgan, {W. R.} and H. Zincke and Rainwater, {L. M.} and Myers, {R. P.} and Klee, {G. G.}",
year = "1991",
language = "English (US)",
volume = "145",
pages = "319--323",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Prostate specific antigen values after radical retropubic prostatectomy for adenocarcinoma of the prostate

T2 - Impact of adjuvant treatment (Hormonal and radiation)

AU - Morgan, W. R.

AU - Zincke, H.

AU - Rainwater, L. M.

AU - Myers, R. P.

AU - Klee, G. G.

PY - 1991

Y1 - 1991

N2 - Prostate specific antigen (PSA) levels were obtained before and after radical retropubic prostatectomy in 192 patients: 78 (41%) had pathological stage B2 cancer or less, 83 (43%) had stage C or C+ and 31 (16%) had stage D1 disease. Of those with stages B2 or less, C, C+ and D1 disease 82, 86, 65 and 90%, respectively, had postoperative PSA values of 0.2 ng./ml. or less (when first evaluated 30 or more days postoperatively). At 1 year postoperatively 94% of the stages C and C+ cancer patients treated with adjuvant radiation had PSA levels of 0.2 ng./ml. or less, which was significantly different from those not treated adjuvantly (p = 0.02). This effect of adjuvant radiation on PSA was temporary in the small number of patients with longer followup. Adjuvant orchiectomy for stage D1 lesions resulted in female PSA levels in virtually all cases. This decrease may be misleading and may reflect a direct hormonal effect rather than a decrease in tumor volume. Positive surgical margins did not significantly affect postoperative PSA levels, possibly because of the frequent use of adjuvant treatment.

AB - Prostate specific antigen (PSA) levels were obtained before and after radical retropubic prostatectomy in 192 patients: 78 (41%) had pathological stage B2 cancer or less, 83 (43%) had stage C or C+ and 31 (16%) had stage D1 disease. Of those with stages B2 or less, C, C+ and D1 disease 82, 86, 65 and 90%, respectively, had postoperative PSA values of 0.2 ng./ml. or less (when first evaluated 30 or more days postoperatively). At 1 year postoperatively 94% of the stages C and C+ cancer patients treated with adjuvant radiation had PSA levels of 0.2 ng./ml. or less, which was significantly different from those not treated adjuvantly (p = 0.02). This effect of adjuvant radiation on PSA was temporary in the small number of patients with longer followup. Adjuvant orchiectomy for stage D1 lesions resulted in female PSA levels in virtually all cases. This decrease may be misleading and may reflect a direct hormonal effect rather than a decrease in tumor volume. Positive surgical margins did not significantly affect postoperative PSA levels, possibly because of the frequent use of adjuvant treatment.

KW - Adenocarcinoma

KW - Antigens, differentiation

KW - Hormone

KW - Prostate

KW - Radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=0025976684&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025976684&partnerID=8YFLogxK

M3 - Article

VL - 145

SP - 319

EP - 323

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 2

ER -